Subscribe To
Ani pharmaceuticals is undervalued when considering their unadvertised pipeline
ANIP Pharmaceuticals has not yet published a pipeline of products under development or out-licensed, leaving investors in the dark about future revenu...
July 5, 2023, 12:51 am
Vertex: promising prospects amid stretched valuation
Vertex Pharmaceuticals saw a 13% increase in Q1 2023 product revenue to $2.37 billion, primarily due to the robust uptake of its cystic fibrosis
July 4, 2023, 11:10 pm
Atricure to announce second quarter 2023 financial results
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments...
July 3, 2023, 8:00 am
Pasithea therapeutics confirms previous creation of independent special committee of its board of directors
Special Committee Continues to Actively Evaluate Unsolicited Proposal from Lucy Scientific Discovery Inc. PALO ALTO, Calif. and MIAMI, June 30, 2023 (...
June 30, 2023, 1:28 pm
Verve therapeutics gains 20.74% in june as ark funds invest
Verve, which was founded in 2018 and went public in June 2021, is developing gene-editing treatments, d...
June 30, 2023, 7:21 am
Merus stock jumps 10% after fda's action on cancer drug
Shares of Merus NV MRUS, +3.02% rallied as much as 10% in the extended session Thursday after the pharma company said the U.S. Food and Drug Administr...
June 29, 2023, 4:43 pm
Eli lilly to buy sigilon therapeutics to expand diabetes treatments
Eli Lilly and Co said on Thursday it will acquire all the shares of Sigilon Therapeutics that it did not own to gain access to experimental cell thera...
June 29, 2023, 8:13 am
Is bluebird bio stock a buy now?
Bluebird's approved treatments still are not generating much by way of sales. The company's next candid...
June 29, 2023, 7:45 am
After ‘transformative' year, roivant aims to challenge bigger rivals in inflammation and immunology
After surviving some turbulent market conditions in its first years as a public company, Roivant Sciences Ltd. ROIV, +10.77% is taking on industry beh...
June 28, 2023, 3:40 pm
Eton pharmaceuticals receives complete response letter (crl) for dehydrated alcohol injection
DEER PARK, Ill., June 28, 2023 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developi...
June 28, 2023, 10:50 am
Psychedelic clinical trials: a glimpse at hotly-anticipated upcoming results
As part of the renewed interest in the potential health applications of psychedelics in recent years, companies ranging from biotechnology startups t...
June 27, 2023, 4:01 pm
Factbox: weight-loss drugs: the next gold rush
Drug developers are chasing an obesity drug gold rush that may be worth up to $100 billion by rolling out trea...
June 27, 2023, 10:56 am
Amyotrophic lateral sclerosis treatment market to reach us$ 594.1 million in 2031, expanding at a cagr of 5.5%: tmr report
Increased consumer and medical professional knowledge regarding novel treatments is predicted to drive ...
June 26, 2023, 5:30 pm
Weight-loss drugs in development aim to replace injections with pills
Wall Street's obsession with next-generation obesity and diabetes treatments intensified over the weeke...
June 26, 2023, 3:21 pm
Retinalgenix technologies, inc. nears completion of institutional review board for research on dna/gps program
Study Intends To Identify Hematology Biomarkers That May Help Personalize Medical Evaluations For Patients Undergoing ...
June 26, 2023, 10:15 am
Enterin presents data demonstrating strong benefit of ent-03 on body weight, adiposity and blood glucose vs. semaglutide in a diet induced obesity mouse model
Data presented at the American Diabetes Association 83rd Scientific Sessions PHILADELPHIA, June 24, 2023 (GLOBE NEWSWIRE) — Enterin Inc., a privatel...
June 24, 2023, 12:00 pm
Carmot therapeutics highlights clinical data from its pipeline of treatments for obesity and diabetes at the 83rd american diabetes association scientific sessions
– Once-weekly administration of CT-388 delivers clinically meaningful weight loss and metabolic control with a favorable tolerability profile over a...
June 24, 2023, 1:30 am
Sarepta therapeutics downgraded at evercore isi after fda approval of gene therapy
Sarepta Therapeutics Inc. SRPT, -2.33%, which yesterday scored a win with U.S. Food and Drug Administration approval of the first gene therapy for chi...
June 23, 2023, 8:21 am
Disc medicine announces closing of public offering of common stock and pre-funded warrants including full exercise of underwriters’ option to purchase additional shares
WATERTOWN, Mass., June 22, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on ...
June 22, 2023, 8:15 pm
Altis labs closes $7.9 million cad to evaluate cancer treatments using ai
Toronto-based Altis Labs, which helps biopharmaceutical companies analyze medical imaging and expedite clinical trials using artificial intelligence (...
June 22, 2023, 6:14 pm
